Biotechs in the green after last week's carnage

The Nasdaq Biotech Index opened positively as many of the larger names-Biogen Idec, Celgene, Gilead Sciences-recovered from dips and companies including Lexicon Pharmaceuticals turned in positive clinical trial data.